404 related articles for article (PubMed ID: 27595104)
1. A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation.
Mezzasalma V; Manfrini E; Ferri E; Sandionigi A; La Ferla B; Schiano I; Michelotti A; Nobile V; Labra M; Di Gennaro P
Biomed Res Int; 2016; 2016():4740907. PubMed ID: 27595104
[TBL] [Abstract][Full Text] [Related]
2. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms: A Randomized, Double-Blind, Placebo-controlled, Multicenter Trial.
Francavilla R; Piccolo M; Francavilla A; Polimeno L; Semeraro F; Cristofori F; Castellaneta S; Barone M; Indrio F; Gobbetti M; De Angelis M
J Clin Gastroenterol; 2019 Mar; 53(3):e117-e125. PubMed ID: 29688915
[TBL] [Abstract][Full Text] [Related]
4. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
5. Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study.
Yoon JY; Cha JM; Oh JK; Tan PL; Kim SH; Kwak MS; Jeon JW; Shin HP
Dig Dis Sci; 2018 Oct; 63(10):2754-2764. PubMed ID: 29876777
[TBL] [Abstract][Full Text] [Related]
6. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
Kajander K; Krogius-Kurikka L; Rinttilä T; Karjalainen H; Palva A; Korpela R
Aliment Pharmacol Ther; 2007 Aug; 26(3):463-73. PubMed ID: 17635381
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Probiotic Escherichia coli Nissle 1917 in Patients with Irritable Bowel Syndrome: a Double Blind Placebo-controlled Randomized Trial.
Faghihi AH; Agah S; Masoudi M; Ghafoori SM; Eshraghi A
Acta Med Indones; 2015 Jul; 47(3):201-8. PubMed ID: 26586385
[TBL] [Abstract][Full Text] [Related]
8. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
[TBL] [Abstract][Full Text] [Related]
9. The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome.
Hod K; Dekel R; Aviv Cohen N; Sperber A; Ron Y; Boaz M; Berliner S; Maharshak N
Neurogastroenterol Motil; 2018 Dec; 30(12):e13456. PubMed ID: 30136337
[TBL] [Abstract][Full Text] [Related]
10. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS.
Hod K; Sperber AD; Ron Y; Boaz M; Dickman R; Berliner S; Halpern Z; Maharshak N; Dekel R
Neurogastroenterol Motil; 2017 Jul; 29(7):. PubMed ID: 28271623
[TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
Ludidi S; Jonkers DM; Koning CJ; Kruimel JW; Mulder L; van der Vaart IB; Conchillo JM; Masclee AA
Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932
[TBL] [Abstract][Full Text] [Related]
14. Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes.
Lyra A; Krogius-Kurikka L; Nikkilä J; Malinen E; Kajander K; Kurikka K; Korpela R; Palva A
BMC Gastroenterol; 2010 Sep; 10():110. PubMed ID: 20849659
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: A randomized controlled trial.
Baştürk A; Artan R; Yılmaz A
Turk J Gastroenterol; 2016 Sep; 27(5):439-443. PubMed ID: 27782892
[TBL] [Abstract][Full Text] [Related]
16. Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic.
Charbonneau D; Gibb RD; Quigley EM
Gut Microbes; 2013; 4(3):201-11. PubMed ID: 23549409
[TBL] [Abstract][Full Text] [Related]
17. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
Bittner AC; Croffut RM; Stranahan MC
Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
[TBL] [Abstract][Full Text] [Related]
19.
Mourey F; Decherf A; Jeanne JF; Clément-Ziza M; Grisoni ML; Machuron F; Legrain-Raspaud S; Bourreille A; Desreumaux P
World J Gastroenterol; 2022 Jun; 28(22):2509-2522. PubMed ID: 35979259
[TBL] [Abstract][Full Text] [Related]
20. Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome.
Ng SC; Lam EF; Lam TT; Chan Y; Law W; Tse PC; Kamm MA; Sung JJ; Chan FK; Wu JC
J Gastroenterol Hepatol; 2013 Oct; 28(10):1624-31. PubMed ID: 23800182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
